Extensive liver resection in a child with an extremely low future liver remnant volume

Cover Page

Cite item

Full Text

Abstract

The incidence of posthepatectomy liver failure in adult patients and a large number of complications of two-stage liver resections require a search for criteria that allow highly accurate assessment of the risk of liver failure. For this purpose, the study of the future liver remnant volume and function have been widely introduced among adult patients, and the future liver remnant function measurement reflects the greater sensitivity. The absence of references to posthepatectomy liver failure, as well as the experience of determining the functional reserve of the future liver remnant in children, let us to suggest the possibility of a wider using one-stage liver resections when the future liver remnant volume is below the generally accepted threshold (25% of the healthy liver parenchyma volume) in the case of the functional reserve sufficient value. This clinical case describes the successful extended right hemihepatectomy and segmentectomy 1 in a 3-year patient with a future liver remnant volume of 16.5% without clinical signs of postresection hepatic failure, which confirms the thesis of the need to assess the functional liver reserve in pediatric oncology to reduce the frequency of two-stage resections and liver transplants. The patient’s parents gave consent to the use of their child’s data, including photographs, for research purposes and in publications. 

About the authors

D. G. Akhaladze

Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Healthcare of the Russian Federation

Author for correspondence.
Email: d.g.akhaladze@gmail.com
ORCID iD: 0000-0002-1387-209X

cand. med. sci., Head of Thoracoabdominal Surgery Group,

1 Samory Mashela St., Moscow 117997

Russian Federation

G. S. Rabaev

Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Healthcare of the Russian Federation

Email: rabaevgesha@gmail.com
ORCID iD: 0000-0002-5691-2522

1 Samory Mashela St., Moscow 117997

Russian Federation

N. N. Merkulov

Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Healthcare of the Russian Federation

Email: dr.mernick@yandex.ru
ORCID iD: 0000-0003-0404-6420

1 Samory Mashela St., Moscow 117997

Russian Federation

I. V. Tverdov

Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Healthcare of the Russian Federation

Email: twerdov.iwan@yandex.ru
ORCID iD: 0000-0001-5150-1436

1 Samory Mashela St., Moscow 117997

Russian Federation

N. S. Grachev

Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Healthcare of the Russian Federation

Email: nick-grachev@yandex.ru
ORCID iD: 0000-0002-4451-3233

1 Samory Mashela St., Moscow 117997

Russian Federation

References

  1. Koerkamp B.G., Wiggers J.K., Gonen M., Doussot A., Allen P.J., Besselink M.G.H., et al. Survival after resection of perihilar cholangiocarcinoma-development and external validation of a prognostic nomogram. Ann Oncol 2015; 26 (9): 1930–5. doi: 10.1093/annonc/mdv279
  2. Vibert E., Pittau G., Gelli M., Cunha A.S., Jamot L., Faivre J., et al. Actual incidence and long-term consequences of posthepatectomy liver failure after hepatectomy for colorectal liver metastases. Surgery 2014; 155 (1): 94–105. doi: 10.1016/j.surg.2013.05.039
  3. Cieslak K.P., Runge J.H., Heger M., Stoker J., Bennink R.J., Van Gulik T.M. New perspectives in the assessment of future remnant liver. Dig Surg 2014; 31 (4–5): 255–68. doi: 10.1159/000364836
  4. Clavien P.A., Petrowsky H., DeOliveira M.L., Graf R. Strategies for Safer Liver Surgery and Partial Liver Transplantation. N Engl J Med 2007; 356 (15): 1545–59. doi: 10.1056/nejmra065156
  5. Vauthey J.N., Chaoui A., Do K.A., Bilimoria M.M., Fenstermacher M.J., Charnsangavej С., et al. Standardized measurement of the future liver remnant prior to extended liver resection: Methodology and clinical associations. Surgery 2000; 127 (5): 512–9. doi: 10.1067/msy.2000.105294
  6. Kauffmann R., Fong Y. Post-hepatectomy liver failure. Hepatobiliary Surg Nutr 2014; 3 (5): 238–46. doi: 10.3906/sag-2006-31
  7. Ribero D., Zimmitti G., Aloia T.A., Shindoh J., Forchino F., Amisano M., et al. Preoperative cholangitis and future liver remnant volume determine the risk of liver failure in patients undergoing resection for hilar cholangiocarcinoma. J Am Coll Surg 2016; 223 (1): 87–97. doi: 10.1016/j.jamcollsurg.2016.01.060
  8. Shoup M., Gonen M., D’Angelica M., Jarnagin W.R., DeMatteo R.P., Schwartz L.H., et al. Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection. J Gastrointest Surg 2003; 7 (3): 325–30. doi: 10.1016/S1091-255X(02)00370-0
  9. De Graaf W., Van Lienden K.P., Dinant S., Roelofs J., Busch O., Gouma D.J., et al. Assessment of future remnant liver function using hepatobiliary scintigraphy in patients undergoing major liver resection. J Gastrointest Surg 2010; 14 (2): 369–78. doi: 10.1007/s11605-009-1085-2
  10. Van Den Broek M., Olde Damink S., Dejong C., Lang H., Malago M., Jalan R., et al. Liver failure after partial hepatic resection: Definition, pathophysiology, risk factors and treatment. Liver Int 2008; 28 (6): 767–80. doi: 10.1111/j.1478-3231.2008.01777.x
  11. Yokoyama Y., Nagino M., Nimura Y. Mechanism of impaired hepatic regeneration in cholestatic liver. J Hepatobiliary Pancreat Surg 2007; (14): 159–66. doi: 10.1007/s00534-006-1125-1
  12. Olthof P.B., Coelen R., Bennink R.J., Heger M., Lam M.F., Besselink M.G., et al. 99mTc-mebrofenin hepatobiliary scintigraphy predicts liver failure fol lowing major liver resection for perihilar cholangiocarcinoma. HPB (Oxford) 2017; 19 (10): 850–8. doi: 10.1016/j.hpb.2017.05.007
  13. Xu Z.L., Wang L., Fan W., Hao Z.H., Li C. ALPPS for hepatic mesenchymal hamartoma in an infant. J Pediatr Surg Case Rep 2018; 37 (July): 70–3. doi: 10.1016/j.epsc.2018.07.023
  14. Cesar J., Gilberto S., Mattos E., Coelho I.M., Ledesma J.A., Conceicao A.F., et al. Associating liver partition with portal vein ligation and staged hepatectomy (ALPPS ) for the treatment of liver tumors in children. J Pediatr Surg 2015; 50 (7): 1227–31. doi: 10.1016/j.jpedsurg.2014.10.019
  15. Chan A., Chung P., Poon R. Little girl who conquered the “ALPPS”. World J Gastroenterol 2014; 20 (29): 10208– 11. doi: 10.3748/wjg.v20.i29.10208
  16. Ахаладзе Д.Г. Оправдана ли операция ALPPS у детей? Хирургия. Журнал им. Н.И. Пирогова 2021; (2): 101–5. doi: 10.17116/hirurgia2021021101
  17. Balzan S., Belghiti J., Farges O., Ogata S., Sauvanet A., Delefosse D., et al. The “50-50 criteria” on postoperative day 5: An accurate predictor of liver failure and death after hepatectomy. Ann Surg 2005; 242 (6): 824–9. doi: 10.1097/01.sla.0000189131.90876.9e
  18. Rahbari N.N., Garden O.J., Padbury R., Brooke-Smith M., Crawford M., Adam R., et al. Posthepatectomy liver failure: A definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery 2011; 149 (5): 713–24. doi: 10.1016/j.surg.2010.10.001
  19. Hong J.C., Kim J., Browning M., Wagner A., Lerret S., Segura A.D., et al. Modified Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy for Hepatoblastoma in a Small Infant. Ann Surg 2017; 266 (2): e16–7. doi: 10.1097/SLA.0000000000002217
  20. Сидоров Д.В., Рябов А.Б., Врублевский С.Г., Трунов В.О., Ложкин М.В., Глазунов А.А. и др. Двухэтапная резекция печени (ALLPS) у ребенка с гигантской эмбриональной саркомой. Детская хирургия 2017; 21 (1): 47–50
  21. Sandstrom P., Rosok B.I., Sparrelid E., Larsen P.N., Larsson A.L., Lindell G., et al. ALPPS Improves Resectability Compared with Conventional Two-stage Hepatectomy in Patients with Advanced Colorectal Liver Metastasis: Results from a Scandinavian Multicenter Randomized Controlled Trial (LIGRO Trial). Ann Surg 2018; 267 (5): 833–40. doi: 10.1097/SLA.0000000000002511
  22. Lang H. ALPPS – Beneficial or detrimental? Surg Oncol 2020; 33 (October): 249–53. doi: 10.1016/j.suronc.2019.10.013
  23. Matsuo K., Murakami T., Kawaguchi D., Hiroshima Y., Koda K., Yamazaki K., et al. Histologic features after surgery associating liver partition and portal vein ligation for staged hepatectomy versus those after hepatectomy with portal vein embolization. Surgery 2016; 159 (5): 1289–98. doi: 10.1016/j.surg.2015.12.004
  24. Tomassini F., D’Asseler Y., Linecker M., Giglio M.C., Castro-Benitez C., Truant S., et al. Hepatobiliary scintigraphy and kinetic growth rate predict liver failure after ALPPS: a multi-institutional study. HPB (Oxford) 2020; 22 (10): 1420–8. doi: 10.1016/j.hpb.2020.01.010
  25. Ratti F., Schadde E., Masetti M., Massani M., Zanello M., Serenari M., et al. Strategies to Increase the Resectability of Patients with Colorectal Liver Metastases: A Multi-center CaseMatch Analysis of ALPPS and Conventional Two-Stage Hepatectomy. Ann Surg Oncol 2015; 22 (6): 1933– 42. doi: 10.1245/s10434-014-4291-4
  26. Belghiti J., Dokmak S., Schadde E. ALPPS: Innovation for innovation’s sake. Surg (United States). 2016; 159 (5): 1287–8. doi: 10.1016/j.surg.2015.12.027
  27. Chan A., Zhang W.Y., Chok K., Dai J., Ji R., Kwan C., et al. ALPPS Versus Portal Vein Embolization for Hepatitis-related Hepatocellular Carcinoma. Ann Surg 2019; 20: 1–9. doi: 10.1097/sla.0000000000003433
  28. Rassam F., Olthof P.B., Bennink R.J., Van Culik T.M. Current Modalities for the Assessment of Future Remnant Liver Function. Visc Med 2017; 33: 442–8. doi: 10.1159/000480385
  29. De Graaf W., Bennink R.J., Vetelainen R., van Gulik T.M. Nuclear imaging techniques for the assessment of hepatic function in liver surgery and transplantation. J Nucl Med 2010; 51 (5): 742–52. doi: 10.2967/jnumed.109.069435
  30. Olthof P.B., Tomassini F., Huespe P.E., Truant S., Pruvot F.R., Troisi R.I., et al. Hepatobiliary scintigraphy to evaluate liver function in associating liver partition and portal vein ligation for staged hepatectomy: Liver volume overestimates liver function. Surgery 2017; 162 (4): 775–83. doi: 10.1016/j.surg.2017.05.022
  31. Chapelle T., Op De Beeck B., Huyghe I., Francque S., Driessen E., Roeyen G., et al. Future remnant liver function estimated by combining liver volumetry on magnetic resonance imaging with total liver function on 99mTc-mebrofenin hepatobiliary scintigraphy: Can this tool predict post-hepatectomy liver failure? HPB (Oxford) 2016; 18 (6): 494–503. doi: 10.1016/j.hpb.2015.08.002
  32. Rassam F., Uz Z., Van Lienden K.P., Ince C., Bennink R.J., Van Gulik T.M. Quantitative assessment of liver function using hepatobiliary scintigraphy: The effect of microcirculatory alterations after portal vein embolization. Nucl Med Commun 2019; 40 (7): 720–6. doi: 10.1097/MNM.0000000000001012
  33. Barseghyan K., Ramanathan R., Chavez T., Harlan S., Lin C.H., Mitsinikos T., et al. Utility of hepatobiliary scintigraphy in diagnosing or excluding biliary atresia in premature neonates and full-term infants with conjugated hyperbilirubinemia who received parenteral nutrition. J Matern Neonatal Med 2018; 31 (24): 3249–54. doi: 10.1080/14767058.2017.1368479
  34. Morland D., Digeon B., Lalire P., Carsin-Vu A., Dejust S., Papathanassiou D. Usefulness of Hepatobiliary Scintigraphy in the Evaluation of Hepatic Cystic Lesions in Children. J Pediatr 2016; 177: 332–332.e2. doi: 10.1016/j.jpeds.2016.06.031
  35. Holdar S., Alsaleem B., Asery A., Al-Hussaini A. Outcome of biliary atresia among Saudi children: A tertiary care center experience. Saudi J Gastroenterol 2019; 25 (3): 176–80. doi: 10.4103/sjg.SJG_306_18
  36. Kousik V., Bhattacharya A., Yadav T.D., Mittal B.R. Hepatobiliary Scintigraphy – Role in Preliminary Diagnosis and Management of Biliary Tract Injuries. Clin Nucl Med 2020; 45 (1): E1–7. doi: 10.1097/RLU.0000000000002830
  37. Ruiz Figueroa E.F., Fernández-Placencia R.M., Berrospi Espinoza F.E., Gomez H.F., Chávez Passiuri I.K. Monosegmental ALPPS: a long-term survival alternative to liver transplant in PRETEXT IV hepatoblastoma. J Surg Case Rep 2019; 2019 (5): 1–4. doi: 10.1093/jscr/rjz144
  38. Ries L.A.G., Smith M.A., Gurney J.G., Linet M., Tamra T., Young J.L., Bunin G.R. Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975–1995, National Cancer Institute, SEER Program. NIH Pub. No. 99–4649. Bethesda, MD; 1999.
  39. Akhaladze D., Uskova N., Rabaev G., Kachanov D., Grachev N. A minimally invasive first stage of ALPPS for hepatoblastoma in a child. Ann Hepatobiliary Pancreat Surg 2020; 24 (3): 352–6. doi: 10.14701/ahbps.2020.24.3.352
  40. Ким Э.Ф., Филин А.В., Семенков А.В., Ушакова И.А., Бурмистров Д.С., Метелин А.В. и др. Двухэтапная обширная резекция печени при гепатобластоме: первый отечественный опыт. Журнал им. акад. Б.В. Петровского 2013; 2: 28–35.
  41. Qazi A.Q., Syed A.A., Khan A.W., Hanif F. Early multifocal recurrence of hepatoblastoma in the residual liver after R0 liver resection with ALPPS procedure: A case report. Ann Transl Med 2016; 4 (19): 2–5. doi: 10.21037/atm.2016.10.01

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2021 Akhaladze D.G., Rabaev G.S., Merkulov N.N., Tverdov I.V., Grachev N.S.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.